SSR240600C

DRUG2 trials

Sponsors

Sanofi

Conditions

Overactive Bladder

Phase 2

MILADY: A Randomized, Placebo-controlled Safety and Efficacy Trial of SSR240600C in Treatment of Overactive Bladder or Urge Urinary Incontinence.

CompletedNCT00174798

SanofiOveractive Bladder

Start: 2005-05-31End: 2006-05-31Updated: 2012-02-02

SSR240600C Treatment in Women With Overactive Bladder

CompletedNCT00564226

SanofiOveractive Bladder

Start: 2007-11-30End: 2009-02-28Updated: 2016-05-26